Encounter for prophylactic rabies immune globin
ICD-10 Z29.14 is a billable code used to indicate a diagnosis of encounter for prophylactic rabies immune globin.
Z29.14 is used to document encounters for the administration of prophylactic rabies immune globulin, typically following potential exposure to rabies through animal bites or scratches. This preventive measure is crucial in mitigating the risk of rabies, a viral disease that is almost universally fatal once symptoms appear. Factors influencing health status include the patient's exposure history, vaccination status, and the type of animal involved. Social determinants such as access to healthcare, education about rabies prevention, and community awareness of rabies risks play a significant role in the timely administration of this treatment. Preventive care is emphasized in high-risk populations, including those in endemic areas or those working with animals. Screening for potential rabies exposure is essential, and aftercare may involve monitoring for adverse reactions to the immune globulin. Accurate coding ensures proper reimbursement and highlights the importance of preventive health measures in public health initiatives.
Documentation must include details of the exposure incident, patient history, and administration of immune globulin.
Routine visits for animal bites, follow-up visits for rabies prophylaxis, and patient education on rabies prevention.
Consideration of social determinants such as patient access to care and education on rabies risks.
Documentation should include population-level data on rabies exposure incidents and vaccination rates.
Community health initiatives focusing on rabies prevention and tracking of rabies exposure cases.
Emphasis on surveillance and reporting to monitor rabies incidence in the community.
Used in conjunction with Z29.14 for patients receiving rabies immune globulin after exposure.
Documentation must include the administration details and patient consent.
Primary care providers should ensure proper follow-up care is documented.
Z29.14 should be used when a patient receives prophylactic rabies immune globulin following potential exposure to rabies, such as through an animal bite. Proper documentation of the exposure and clinical rationale is essential.
